Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

NOVT vs CGNX vs MKSI vs VIAV vs IPGP

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
NOVT
Novanta Inc.

Hardware, Equipment & Parts

TechnologyNASDAQ • US
Market Cap$4.86B
5Y Perf.+32.7%
CGNX
Cognex Corporation

Hardware, Equipment & Parts

TechnologyNASDAQ • US
Market Cap$11.01B
5Y Perf.+16.2%
MKSI
MKS Inc.

Hardware, Equipment & Parts

TechnologyNASDAQ • US
Market Cap$20.25B
5Y Perf.+184.8%
VIAV
Viavi Solutions Inc.

Communication Equipment

TechnologyNASDAQ • US
Market Cap$11.81B
5Y Perf.+340.5%
IPGP
IPG Photonics Corporation

Semiconductors

TechnologyNASDAQ • US
Market Cap$4.31B
5Y Perf.-34.6%

NOVT vs CGNX vs MKSI vs VIAV vs IPGP — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
NOVT logoNOVT
CGNX logoCGNX
MKSI logoMKSI
VIAV logoVIAV
IPGP logoIPGP
IndustryHardware, Equipment & PartsHardware, Equipment & PartsHardware, Equipment & PartsCommunication EquipmentSemiconductors
Market Cap$4.86B$11.01B$20.25B$11.81B$4.31B
Revenue (TTM)$981M$1.05B$4.07B$1.37B$1.04B
Net Income (TTM)$54M$143M$327M$-55M$29M
Gross Margin44.4%68.0%45.2%55.7%37.6%
Operating Margin11.9%18.8%14.8%8.2%0.3%
Forward P/E38.2x53.0x30.4x55.2x62.6x
Total Debt$342M$77M$4.69B$692M$0.00
Cash & Equiv.$381M$263M$675M$424M$404M

NOVT vs CGNX vs MKSI vs VIAV vs IPGPLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

NOVT
CGNX
MKSI
VIAV
IPGP
StockMay 20May 26Return
Novanta Inc. (NOVT)100132.7+32.7%
Cognex Corporation (CGNX)100116.2+16.2%
MKS Inc. (MKSI)100284.8+184.8%
Viavi Solutions Inc. (VIAV)100440.5+340.5%
IPG Photonics Corpo… (IPGP)10065.4-34.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: NOVT vs CGNX vs MKSI vs VIAV vs IPGP

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CGNX leads in 4 of 7 categories (5-stock set), making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. MKS Inc. is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. VIAV also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
NOVT
Novanta Inc.
The Long-Run Compounder

NOVT is the clearest fit if your priority is long-term compounding and valuation efficiency.

  • 8.5% 10Y total return vs MKSI's 7.5%
  • PEG 11.61 vs VIAV's 12.09
Best for: long-term compounding and valuation efficiency
CGNX
Cognex Corporation
The Income Pick

CGNX carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.

  • Dividend streak 4 yrs, beta 1.50, yield 0.5%
  • Lower volatility, beta 1.50, Low D/E 5.1%, current ratio 3.80x
  • Beta 1.50, yield 0.5%, current ratio 3.80x
  • 13.6% margin vs VIAV's -4.0%
Best for: income & stability and sleep-well-at-night
MKSI
MKS Inc.
The Growth Play

MKSI is the #2 pick in this set and the best alternative if growth exposure is your priority.

  • Rev growth 9.6%, EPS growth 55.5%, 3Y rev CAGR 3.5%
  • 9.6% revenue growth vs IPGP's 2.7%
  • Lower P/E (30.4x vs 62.6x)
Best for: growth exposure
VIAV
Viavi Solutions Inc.
The Momentum Pick

VIAV ranks third and is worth considering specifically for momentum.

  • +466.6% vs NOVT's +14.6%
Best for: momentum
IPGP
IPG Photonics Corporation
The Technology Pick

Among these 5 stocks, IPGP doesn't own a clear edge in any measured category.

Best for: technology exposure
See the full category breakdown
CategoryWinnerWhy
GrowthMKSI logoMKSI9.6% revenue growth vs IPGP's 2.7%
ValueMKSI logoMKSILower P/E (30.4x vs 62.6x)
Quality / MarginsCGNX logoCGNX13.6% margin vs VIAV's -4.0%
Stability / SafetyCGNX logoCGNXBeta 1.50 vs MKSI's 2.64, lower leverage
DividendsCGNX logoCGNX0.5% yield, 4-year raise streak, vs MKSI's 0.3%, (3 stocks pay no dividend)
Momentum (1Y)VIAV logoVIAV+466.6% vs NOVT's +14.6%
Efficiency (ROA)CGNX logoCGNX7.1% ROA vs VIAV's -2.3%, ROIC 9.0% vs 5.5%

NOVT vs CGNX vs MKSI vs VIAV vs IPGP — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

NOVTNovanta Inc.
FY 2025
Robotics and Automation
32.5%$319M
Advanced Surgery
24.7%$242M
Precision Medicine
24.2%$237M
Precision Manufacturing
18.6%$182M
CGNXCognex Corporation
FY 2025
Standard Product and Services
88.5%$880M
Application of Customer Specific Solutions
11.5%$114M
MKSIMKS Inc.
FY 2025
Product
87.4%$3.4B
Service
12.6%$495M
VIAVViavi Solutions Inc.
FY 2025
Product
84.1%$912M
Service
15.9%$172M
IPGPIPG Photonics Corporation
FY 2025
High Power Continuous Wave CW Lasers
41.8%$309M
Laser And Non-Laser Systems
19.9%$147M
Pulsed Lasers
19.4%$143M
Medium And Low Power CW Lasers
11.9%$88M
Quasi-Continuous Wave QCW Lasers
7.0%$52M

NOVT vs CGNX vs MKSI vs VIAV vs IPGP — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCGNXLAGGINGIPGP

Income & Cash Flow (Last 12 Months)

CGNX leads this category, winning 5 of 6 comparable metrics.

MKSI is the larger business by revenue, generating $4.1B annually — 4.2x NOVT's $981M. CGNX is the more profitable business, keeping 13.6% of every revenue dollar as net income compared to VIAV's -4.0%. On growth, VIAV holds the edge at +42.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricNOVT logoNOVTNovanta Inc.CGNX logoCGNXCognex CorporationMKSI logoMKSIMKS Inc.VIAV logoVIAVViavi Solutions I…IPGP logoIPGPIPG Photonics Cor…
RevenueTrailing 12 months$981M$1.0B$4.1B$1.4B$1.0B
EBITDAEarnings before interest/tax$179M$219M$945M$207M$55M
Net IncomeAfter-tax profit$54M$143M$327M-$55M$29M
Free Cash FlowCash after capex$48M$241M$401M$46M$8M
Gross MarginGross profit ÷ Revenue+44.4%+68.0%+45.2%+55.7%+37.6%
Operating MarginEBIT ÷ Revenue+11.9%+18.8%+14.8%+8.2%+0.3%
Net MarginNet income ÷ Revenue+5.5%+13.6%+8.0%-4.0%+2.8%
FCF MarginFCF ÷ Revenue+4.9%+23.0%+9.8%+3.3%+0.8%
Rev. Growth (YoY)Latest quarter vs prior year+8.5%+24.3%+15.2%+42.8%+16.6%
EPS Growth (YoY)Latest quarter vs prior year-2.2%+121.4%+53.2%-70.2%-54.4%
CGNX leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

MKSI leads this category, winning 4 of 7 comparable metrics.

At 68.8x trailing earnings, MKSI trades at a 80% valuation discount to VIAV's 340.3x P/E. Adjusting for growth (PEG ratio), NOVT offers better value at 28.13x vs VIAV's 74.57x — a lower PEG means you pay less per unit of expected earnings growth.

MetricNOVT logoNOVTNovanta Inc.CGNX logoCGNXCognex CorporationMKSI logoMKSIMKS Inc.VIAV logoVIAVViavi Solutions I…IPGP logoIPGPIPG Photonics Cor…
Market CapShares × price$4.9B$11.0B$20.2B$11.8B$4.3B
Enterprise ValueMkt cap + debt − cash$4.8B$10.8B$24.3B$12.1B$3.9B
Trailing P/EPrice ÷ TTM EPS92.71x96.92x68.83x340.33x139.22x
Forward P/EPrice ÷ next-FY EPS est.38.25x53.05x30.36x55.18x62.62x
PEG RatioP/E ÷ EPS growth rate28.13x74.57x
EV / EBITDAEnterprise value multiple27.00x55.96x26.70x90.43x48.90x
Price / SalesMarket cap ÷ Revenue4.96x11.07x5.15x10.89x4.30x
Price / BookPrice ÷ Book value/share3.81x7.48x7.49x14.77x2.04x
Price / FCFMarket cap ÷ FCF100.38x46.49x40.74x190.52x
MKSI leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

CGNX leads this category, winning 5 of 9 comparable metrics.

MKSI delivers a 12.2% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-7 for VIAV. CGNX carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to MKSI's 1.73x. On the Piotroski fundamental quality scale (0–9), CGNX scores 7/9 vs VIAV's 5/9, reflecting strong financial health.

MetricNOVT logoNOVTNovanta Inc.CGNX logoCGNXCognex CorporationMKSI logoMKSIMKS Inc.VIAV logoVIAVViavi Solutions I…IPGP logoIPGPIPG Photonics Cor…
ROE (TTM)Return on equity+4.1%+9.6%+12.2%-6.9%+1.4%
ROA (TTM)Return on assets+3.0%+7.1%+3.7%-2.3%+1.2%
ROICReturn on invested capital+7.4%+9.0%+6.5%+5.5%+0.6%
ROCEReturn on capital employed+8.3%+8.9%+7.2%+4.9%+0.6%
Piotroski ScoreFundamental quality 0–957656
Debt / EquityFinancial leverage0.26x0.05x1.73x0.89x
Net DebtTotal debt minus cash-$39M-$186M$4.0B$269M-$404M
Cash & Equiv.Liquid assets$381M$263M$675M$424M$404M
Total DebtShort + long-term debt$342M$77M$4.7B$692M$0
Interest CoverageEBIT ÷ Interest expense4.89x2.84x2.70x
CGNX leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

VIAV leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in VIAV five years ago would be worth $31,204 today (with dividends reinvested), compared to $5,151 for IPGP. Over the past 12 months, VIAV leads with a +466.6% total return vs NOVT's +14.6%. The 3-year compound annual growth rate (CAGR) favors VIAV at 77.7% vs NOVT's -5.3% — a key indicator of consistent wealth creation.

MetricNOVT logoNOVTNovanta Inc.CGNX logoCGNXCognex CorporationMKSI logoMKSIMKS Inc.VIAV logoVIAVViavi Solutions I…IPGP logoIPGPIPG Photonics Cor…
YTD ReturnYear-to-date+22.6%+78.7%+78.8%+181.3%+35.8%
1-Year ReturnPast 12 months+14.6%+133.1%+306.1%+466.6%+75.6%
3-Year ReturnCumulative with dividends-15.2%+34.7%+266.0%+461.0%-12.7%
5-Year ReturnCumulative with dividends+5.7%-13.2%+66.5%+212.0%-48.5%
10-Year ReturnCumulative with dividends+853.7%+249.6%+750.6%+715.5%+20.2%
CAGR (3Y)Annualised 3-year return-5.3%+10.4%+54.1%+77.7%-4.4%
VIAV leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CGNX and MKSI each lead in 1 of 2 comparable metrics.

CGNX is the less volatile stock with a 1.50 beta — it tends to amplify market swings less than MKSI's 2.64 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MKSI currently trades 92.0% from its 52-week high vs IPGP's 65.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricNOVT logoNOVTNovanta Inc.CGNX logoCGNXCognex CorporationMKSI logoMKSIMKS Inc.VIAV logoVIAVViavi Solutions I…IPGP logoIPGPIPG Photonics Cor…
Beta (5Y)Sensitivity to S&P 5002.02x1.50x2.64x1.54x1.80x
52-Week HighHighest price in past year$149.95$71.90$326.83$60.43$155.82
52-Week LowLowest price in past year$98.27$27.82$71.49$8.87$53.98
% of 52W HighCurrent price vs 52-week peak+90.9%+91.7%+92.0%+84.5%+65.2%
RSI (14)Momentum oscillator 0–10062.676.365.366.739.7
Avg Volume (50D)Average daily shares traded375K2.0M1.2M6.3M510K
Evenly matched — CGNX and MKSI each lead in 1 of 2 comparable metrics.

Analyst Outlook

CGNX leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: NOVT as "Buy", CGNX as "Hold", MKSI as "Buy", VIAV as "Buy", IPGP as "Buy". Consensus price targets imply 49.2% upside for IPGP (target: $152) vs -36.8% for VIAV (target: $32). For income investors, CGNX offers the higher dividend yield at 0.49% vs MKSI's 0.29%.

MetricNOVT logoNOVTNovanta Inc.CGNX logoCGNXCognex CorporationMKSI logoMKSIMKS Inc.VIAV logoVIAVViavi Solutions I…IPGP logoIPGPIPG Photonics Cor…
Analyst RatingConsensus buy/hold/sellBuyHoldBuyBuyBuy
Price TargetConsensus 12-month target$150.00$60.22$272.86$32.25$151.67
# AnalystsCovering analysts331291927
Dividend YieldAnnual dividend ÷ price+0.5%+0.3%
Dividend StreakConsecutive years of raises4011
Dividend / ShareAnnual DPS$0.32$0.87
Buyback YieldShare repurchases ÷ mkt cap+0.8%+1.4%+0.2%+0.1%+1.3%
CGNX leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

CGNX leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MKSI leads in 1 (Valuation Metrics). 1 tied.

Best OverallCognex Corporation (CGNX)Leads 3 of 6 categories
Loading custom metrics...

NOVT vs CGNX vs MKSI vs VIAV vs IPGP: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is NOVT or CGNX or MKSI or VIAV or IPGP a better buy right now?

For growth investors, MKS Inc.

(MKSI) is the stronger pick with 9. 6% revenue growth year-over-year, versus 2. 7% for IPG Photonics Corporation (IPGP). MKS Inc. (MKSI) offers the better valuation at 68. 8x trailing P/E (30. 4x forward), making it the more compelling value choice. Analysts rate Novanta Inc. (NOVT) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — NOVT or CGNX or MKSI or VIAV or IPGP?

On trailing P/E, MKS Inc.

(MKSI) is the cheapest at 68. 8x versus Viavi Solutions Inc. at 340. 3x. On forward P/E, MKS Inc. is actually cheaper at 30. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Novanta Inc. wins at 11. 61x versus Viavi Solutions Inc. 's 12. 09x.

03

Which is the better long-term investment — NOVT or CGNX or MKSI or VIAV or IPGP?

Over the past 5 years, Viavi Solutions Inc.

(VIAV) delivered a total return of +212. 0%, compared to -48. 5% for IPG Photonics Corporation (IPGP). Over 10 years, the gap is even starker: NOVT returned +853. 7% versus IPGP's +20. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — NOVT or CGNX or MKSI or VIAV or IPGP?

By beta (market sensitivity over 5 years), Cognex Corporation (CGNX) is the lower-risk stock at 1.

50β versus MKS Inc. 's 2. 64β — meaning MKSI is approximately 75% more volatile than CGNX relative to the S&P 500. On balance sheet safety, Cognex Corporation (CGNX) carries a lower debt/equity ratio of 5% versus 173% for MKS Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — NOVT or CGNX or MKSI or VIAV or IPGP?

By revenue growth (latest reported year), MKS Inc.

(MKSI) is pulling ahead at 9. 6% versus 2. 7% for IPG Photonics Corporation (IPGP). On earnings-per-share growth, the picture is similar: Viavi Solutions Inc. grew EPS 225. 0% year-over-year, compared to -16. 9% for Novanta Inc.. Over a 3-year CAGR, NOVT leads at 4. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — NOVT or CGNX or MKSI or VIAV or IPGP?

Cognex Corporation (CGNX) is the more profitable company, earning 11.

5% net margin versus 3. 1% for IPG Photonics Corporation — meaning it keeps 11. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CGNX leads at 16. 3% versus 1. 3% for IPGP. At the gross margin level — before operating expenses — CGNX leads at 66. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is NOVT or CGNX or MKSI or VIAV or IPGP more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Novanta Inc. (NOVT) is the more undervalued stock at a PEG of 11. 61x versus Viavi Solutions Inc. 's 12. 09x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, MKS Inc. (MKSI) trades at 30. 4x forward P/E versus 62. 6x for IPG Photonics Corporation — 32. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IPGP: 49. 2% to $151. 67.

08

Which pays a better dividend — NOVT or CGNX or MKSI or VIAV or IPGP?

In this comparison, CGNX (0.

5% yield), MKSI (0. 3% yield) pay a dividend. NOVT, VIAV, IPGP do not pay a meaningful dividend and should not be held primarily for income.

09

Is NOVT or CGNX or MKSI or VIAV or IPGP better for a retirement portfolio?

For long-horizon retirement investors, Viavi Solutions Inc.

(VIAV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+715. 5% 10Y return). IPG Photonics Corporation (IPGP) carries a higher beta of 1. 80 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VIAV: +715. 5%, IPGP: +20. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between NOVT and CGNX and MKSI and VIAV and IPGP?

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

NOVT

Quality Business

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

CGNX

High-Growth Compounder

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 12%
  • Net Margin > 8%
Run This Screen
Stocks Like

MKSI

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Net Margin > 5%
Run This Screen
Stocks Like

VIAV

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 21%
  • Gross Margin > 33%
Run This Screen
Stocks Like

IPGP

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 8%
  • Gross Margin > 22%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform NOVT and CGNX and MKSI and VIAV and IPGP on the metrics below

Revenue Growth>
%
(NOVT: 8.5% · CGNX: 24.3%)
Net Margin>
%
(NOVT: 5.5% · CGNX: 13.6%)
P/E Ratio<
x
(NOVT: 92.7x · CGNX: 96.9x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.